Phase II study of FOLFOX4 with "wait and go" strategy as first-line treatment for metastatic colorectal cancer.
Phase II study of FOLFOX4 with "wait and go" strategy as first-line treatment for metastatic colorectal cancer. Cancer Chemother Pharmacol. 2011 Nov; 68(5):1215-22.